Covered recipient · General Payments record
WILSON DUMORNAY
Allopathic & Osteopathic Physicians Otolaryngology Facial Plastic Surgery
General Payments · PY2018–2024
$7,961.63
- Reported across 96 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $367.04 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Aroa Biosurgery Incorporated | $64.76 | 1 |
| GENZYME CORPORATION | $63.83 | 2 |
| OptiNose US, Inc. | $62.44 | 3 |
| GlaxoSmithKline, LLC. | $45.60 | 2 |
| Stryker Corporation | $36.57 | 1 |
| Phadia US Inc. | $23.41 | 1 |
| Medtronic, Inc. | $21.91 | 1 |
| Vertical Pharmaceuticals, LLC | $18.76 | 1 |
| AERIN MEDICAL INC. | $15.67 | 1 |
| Ethicon US, LLC | $14.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AERIN MEDICAL INC. | $15.67 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144650250 | CMS |
| Aroa Biosurgery Incorporated | $64.76 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1088815539 | CMS |
| Ethicon US, LLC | $14.09 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077628532 | CMS |
| GENZYME CORPORATION | $34.29 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139713742 | CMS |
| GENZYME CORPORATION | $29.54 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139713844 | CMS |
| GlaxoSmithKline, LLC. | $20.64 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116132354 | CMS |
| GlaxoSmithKline, LLC. | $24.96 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116591187 | CMS |
| Medtronic, Inc. | $21.91 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117126100 | CMS |
| Optinose US, Inc. | $20.47 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142185579 | CMS |
| Optinose US, Inc. | $16.41 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142185593 | CMS |
| Optinose US, Inc. | $25.56 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142185639 | CMS |
| Phadia US Inc. | $23.41 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067587938 | CMS |
| Stryker Corporation | $36.57 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119818815 | CMS |
| Vertical Pharmaceuticals, LLC | $18.76 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126994722 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.